Author： Cazzola Mario Rogliani Paola Segreti Andrea Matera Maria Gabriella
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.10, 2012-10, pp. : 1489-1501
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Randomized Phase II Clinical Trials
Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. :
Access to resources
Recommend
Ethical Issues in Phase I Cancer Clinical Trials
International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. :
An Adaptive Design for Phase II Non-Oncology Dose Selection Clinical Trials
By Su Zheng
Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. :